State OR
Clinical Trials in Oregon
Recruiting clinical trials with at least one study location in Oregon. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oregon
Malignant Solid Neoplasm (5)Advanced Solid Tumor (5)Prostate Cancer (4)Acute Myeloid Leukemia (4)Parkinson Disease (4)Myeloproliferative Neoplasm (3)Hematopoietic and Lymphatic System Neoplasm (3)Acute Lymphoblastic Leukemia (3)Atopic Dermatitis (3)Breast Cancer (3)Acute Respiratory Distress Syndrome (3)NSCLC (Non-small Cell Lung Cancer) (3)
NCT04349436 Phase 1, Phase 2
Recruiting
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ...
Condition
Merkel Cell Carcinoma
Enrollment
90 pts
Location
United States
Sponsor
Replimune Inc.
NCT05703971 Phase 1, Phase 2
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SC...
Condition
Small Cell Lung Cancer Extensive Stage
Enrollment
62 pts
Location
United States
Sponsor
Genprex, Inc.
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT07276399 Phase 3
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared Wit...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
500 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT07258511 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 ...
Condition
Multiple Myeloma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults ...
Condition
Dravet Syndrome
Enrollment
160 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06465953 Phase 3
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With ...
Condition
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
Enrollment
48 pts
Location
United States, Australia, Brazil
Sponsor
Institut de Recherches Interna
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT06921902 N/A
Recruiting
Glycemic Metrics and Patterns in People With and Without Prediabetes
Condition
Pre Diabetes
Enrollment
2,000 pts
Location
United States
Sponsor
Abbott Diabetes Care
NCT06130553 Phase 1, Phase 2
Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/...
Condition
Advanced Solid Tumors That Are MTAP Deficient
Enrollment
234 pts
Location
United States, Australia, China
Sponsor
AstraZeneca
NCT05748873 Phase 1, Phase 2
Recruiting
Promising ROd-cone DYstrophy Gene therapY
Condition
Retinitis Pigmentosa
Enrollment
33 pts
Location
United States, France
Sponsor
SparingVision
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05763953 Phase 2
Recruiting
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
Condition
Paroxysmal Supraventricular Tachycardia
Enrollment
60 pts
Location
United States, Canada, Germany
Sponsor
Milestone Pharmaceuticals Inc.
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT06435000 N/A
Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Diseas...
Condition
Stargardt
Enrollment
75 pts
Location
United States, Germany, United Kingdom
Sponsor
Splice Bio
NCT04524871 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treat...
Condition
Advanced Liver Cancers
Enrollment
518 pts
Location
United States, China, France
Sponsor
Hoffmann-La Roche
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
NCT00237315 N/A
Recruiting
Longitudinal Study of Urea Cycle Disorders
Condition
Brain Diseases, Metabolic, Inborn
Enrollment
1,500 pts
Location
United States, Canada, Germany
Sponsor
Andrea Gropman